Stryker Sustainability Profile
Stryker Corporation, commonly referred to as Stryker, is a leading global medical technology company headquartered in the United States. Founded in 1941, Stryker has established itself as a key player in the orthopaedics, surgical equipment, and neurotechnology sectors, with significant operations across North America, Europe, and Asia-Pacific. The company is renowned for its innovative products, including advanced surgical instruments, implantable devices, and patient handling solutions, which are designed to enhance surgical outcomes and improve patient care. Stryker's commitment to quality and innovation has positioned it as a trusted partner in the healthcare industry, earning numerous accolades for its contributions to medical technology. With a strong market presence, Stryker continues to lead the way in developing cutting-edge solutions that address the evolving needs of healthcare professionals and patients alike.
DitchCarbon Score
How does Stryker's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Stryker's score of 41 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Stryker's reported carbon emissions
In 2023, Stryker Corporation reported total Scope 2 emissions of approximately 49,703,000 kg CO2e in North America and about 16,286,000 kg CO2e in Uganda. Globally, their Scope 1 emissions were approximately 25,402,000 kg CO2e, while Scope 2 emissions totalled around 136,473,000 kg CO2e, leading to a combined total of about 191,056,000 kg CO2e for Scope 1 and 2 emissions on a market-based approach. Stryker has set ambitious climate commitments, aiming for carbon neutrality in both Scope 1 and Scope 2 emissions by 2030. Additionally, they have established an interim target to achieve a 20% reduction in Scope 1 and 2 emissions by 2024, using 2019 as a baseline. This commitment reflects their dedication to sustainability and aligns with industry standards for greenhouse gas reduction. The company’s emissions data is sourced directly from Stryker Corporation, with no cascaded data from parent or related organizations. Stryker's ongoing efforts to enhance sustainability are integral to their mission of improving healthcare while addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 27,076,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 146,705,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
How Carbon Intensive is Stryker's Industry?
How Carbon Intensive is Stryker's Location?
Stryker's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Stryker has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Frequently Asked Questions
Common questions about Stryker's sustainability data and climate commitments